Dr. Litvack is a native of Canada. He completed medical school and an internal medicine residency at McGill University in Montreal and a Cardiovascular Fellowship at Cedars-Sinai Medical Center in Los Angeles, where he subsequently became Co-Director of the Cardiovascular Intervention Center and Professor of Medicine at UCLA. There he led a prominent clinical and research program known for its excellence in innovation, care and leadership in Translational Medicine. Dr. Litvack was Board certified in Internal Medicine, Cardiovascular Diseases and Interventional Cardiology. He has published more than one hundred research articles and chapters and is the recipient of several awards including an American Heart Association Young Investigator Award, the Leon Goldman Medical Excellence Award for contributions to the field of biomedical optics and the United States Space Technology and Space Foundation Hall of Fame for pioneering work with excimer lasers. Dr. Litvack left full time practice and academics in 2000 to concentrate on entrepreneurial activities.

Dr. Litvack has founded and/or operated several healthcare ventures both as chairman and/or CEO, including Advanced Interventional Systems Inc. (merged with Spectranetics Inc.), Progressive Angioplasty Systems Inc., Savacor Inc., Conor Medsystems Inc. and Entourage Medical Technologies Inc. He is presently Executive Chairman of several ventures including Capricor Therapeutics Inc., and Credence MedSystems Inc. He has overseen both the sale and/or public offerings of several of these ventures. Dr. Litvack is a Co-Founder and General Partner in Pura Vida Investments LLC, a health care focused Hedge Fund. In addition he sits on the Boards of several early stage health care companies.